Literature DB >> 19426115

MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases.

Maria Angelica Cortez1, George Adrian Calin.   

Abstract

MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression at the posttranscriptional level by degrading or blocking translation of messenger RNA (mRNA) targets. MiRNAs play important regulatory roles in a variety of cellular functions as well as in several diseases, including cancer. MiRNA-specific expression profiles have been reported for several pathological conditions. Recently, the discovery of miRNAs in serum opens up the possibility of using miRNAs as biomarkers of disease. In this review, we discuss the potential use of miRNAs as clinically diagnostic biomarkers of various cancers and other diseases as well as the approaches used to detect these molecules in serum and plasma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426115     DOI: 10.1517/14712590902932889

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  175 in total

1.  Circulating and renal vein levels of microRNAs in patients with renal artery stenosis.

Authors:  Moo Yong Park; Sandra M Herrmann; Ahmed Saad; Robert Jay Widmer; Hui Tang; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2014-10-31       Impact factor: 5.992

2.  Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.

Authors:  Charlotte Angerstein; Michael Hecker; Brigitte Katrin Paap; Dirk Koczan; Madhan Thamilarasan; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2012-05-02       Impact factor: 5.590

3.  microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer.

Authors:  Riccardo Cazzoli; Fiamma Buttitta; Marta Di Nicola; Sara Malatesta; Antonio Marchetti; William N Rom; Harvey I Pass
Journal:  J Thorac Oncol       Date:  2013-09       Impact factor: 15.609

4.  Effect on Intermittent Hypoxia on Plasma Exosomal Micro RNA Signature and Endothelial Function in Healthy Adults.

Authors:  Abdelnaby Khalyfa; Chunling Zhang; Ahamed A Khalyfa; Glen E Foster; Andrew E Beaudin; Jorge Andrade; Patrick J Hanly; Marc J Poulin; David Gozal
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

Review 5.  Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients.

Authors:  Andrew Fesler; Jingting Jiang; Haiyan Zhai; Jingfang Ju
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

6.  miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions.

Authors:  Eun-Ah Ye; Jena J Steinle
Journal:  Vision Res       Date:  2017-04-26       Impact factor: 1.886

7.  Expression of small nucleolar RNAs in leukemic cells.

Authors:  Kaisa J Teittinen; Asta Laiho; Annemari Uusimäki; Juha-Pekka Pursiheimo; Attila Gyenesei; Olli Lohi
Journal:  Cell Oncol (Dordr)       Date:  2012-11-15       Impact factor: 6.730

Review 8.  Detection of miRNAs with a nanopore single-molecule counter.

Authors:  Li-Qun Gu; Meni Wanunu; Michael X Wang; Larry McReynolds; Yong Wang
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

9.  Circulating miRNA as novel markers for diastolic dysfunction.

Authors:  Nandini Nair; Sandeep Kumar; Enrique Gongora; Sudhiranjan Gupta
Journal:  Mol Cell Biochem       Date:  2012-12-18       Impact factor: 3.396

10.  MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis.

Authors:  Catalin Vasilescu; Simona Rossi; Masayoshi Shimizu; Stefan Tudor; Angelo Veronese; Manuela Ferracin; Milena S Nicoloso; Elisa Barbarotto; Monica Popa; Oana Stanciulea; Michael H Fernandez; Dan Tulbure; Carlos E Bueso-Ramos; Massimo Negrini; George A Calin
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.